Compare AD & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AD | NVST |
|---|---|---|
| Founded | 1983 | 2018 |
| Country | United States | United States |
| Employees | 60 | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.7B |
| IPO Year | N/A | 2019 |
| Metric | AD | NVST |
|---|---|---|
| Price | $36.24 | $27.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 13 |
| Target Price | ★ $55.00 | $26.46 |
| AVG Volume (30 Days) | 402.9K | ★ 2.5M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 69.43% | N/A |
| EPS Growth | N/A | ★ 104.31 |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $2,566,500,000.00 |
| Revenue This Year | $33.57 | $6.67 |
| Revenue Next Year | N/A | $3.55 |
| P/E Ratio | $275.77 | ★ $120.09 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $35.12 | $18.77 |
| 52 Week High | $77.13 | $30.42 |
| Indicator | AD | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 26.85 | 69.60 |
| Support Level | N/A | $22.31 |
| Resistance Level | $50.15 | $29.96 |
| Average True Range (ATR) | 1.33 | 0.76 |
| MACD | -0.23 | 0.28 |
| Stochastic Oscillator | 19.34 | 100.00 |
Array Digital Infrastructure, formerly US Cellular, sold its regional wireless operations serving about 4.4 million customers to T-Mobile in August 2025. The firm has agreed to sell most of its remaining spectrum licenses; however, it will still retain rights to C-band spectrum in several locations after these deals are closed. Array also owns a 5.5% stake in Verizon Wireless' Los Angeles operations, as well as other smaller wireless partnership interests in Oklahoma and upstate New York. The firm still operates a portfolio of about 4,400 wireless towers. Parent TDS has proposed to acquire the portion of Array that it doesn't already own in an all-stock transaction.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.